{"SPADE_UN_17074": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17074", "Peptide Name": "(RXR)4BR", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "RXRRXRRXRRXRXB", "Sequence Length": 14, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C48H86N32O3", "Mass": 194144, "PI": 13.35, "Net Charge": 8, "Hydrophobicity": -2.571, "Half Life": "Mammalian:1 hourYeast:2 minE.coli:2 min", "Literature": [{"Title": "Inhibition of p54 expression by peptide-conjugated phosphorodiamidate morpholino oligomers sensitizes human cancer cells to chemotherapeutic drugs.", "Pubmed ID": "21765469", "Reference": "Oncogene. 2012 Feb 23;31(8)1024-34.", "Author": "Ma W, Lin Y, Xuan W, Iversen PL, Smith LJ, Benchimol S.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=21765469"}], "Frequent Amino Acids": "RXB", "Absent Amino Acids": "ACDEFGHIKLMNOPQSTUVWY", "Basic Residues": 8, "Acidic Residues": 0, "Hydrophobic Residues": 0, "Polar Residues": 8, "Positive Residues": 8, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_06339", "Similarity": 1.0, "Sequence": "RRRRRNWMWC"}, {"SPADE_ID": "SPADE_N_06340", "Similarity": 1.0, "Sequence": "RRRRRWCMNW"}, {"SPADE_ID": "SPADE_N_07025", "Similarity": 1.0, "Sequence": "RRRRRRRRRRRTYADFIASGRTGRRNAI"}]}}}